Change of Control Agreements in the Life Sciences Tools & Services Industry
91 Contracts & Agreements
- Adaptive Biotechnologies Corp (1 contract)
- Agilent Technologies Inc (13)
- Alpha Teknova, Inc. (1)
- ARYA Sciences Acquisition Corp III (10)
- Basis Global Technologies, Inc. (1)
- Berkeley Lights, Inc. (2)
- Bio-Rad Laboratories (1)
- BIOANALYTICAL SYSTEMS INC (0)
- Codex DNA, Inc. (1)
- CODEXIS INC (10)
- FLUIDIGM CORP (8)
- Illumina Inc (7)
- IQVIA Holdings Inc. (1)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (13)
- Repligen Corporation (2)
- Seer, Inc. (2)
- Thermo Fisher Scientific (10)
- VG Acquisition Corp. (1)
- Waters Corporation (7)
- 2024 Change of Control and Severance Plan and Participation Agreement (FLUIDIGM CORP, Filed With SEC on August 30, 2024)
- Change in Control Severance Agreement between Illumina, Inc. and Jacob Thaysen (Illumina Inc, Filed With SEC on September 5, 2023)
- 2023 Change of Control and Severance Plan Participation Agreement, by and between Standard BioTools Inc. and Jeremy Davis, dated June 28, 2023 (FLUIDIGM CORP, Filed With SEC on August 8, 2023)
- 2023 Change of Control and Severance Plan Participation Agreement, by and between Standard BioTools Inc. and Hanjoon Alex Kim, dated July 24, 2023 (FLUIDIGM CORP, Filed With SEC on August 8, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Matthew Murphy, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Subra Sankar, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Mary Godwin, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Gwen Weld, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Nick Nelson, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Anna Mowry, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Parag Mallick, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Sujal Patel, dated as of July 31, 2023 (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2023)
- 2023 Change of Control and Severance Plan (FLUIDIGM CORP, Filed With SEC on July 28, 2023)
- 2023 Change of Control and Severance Plan (FLUIDIGM CORP, Filed With SEC on July 28, 2023)
- Standard BioTools Inc. 2020 Change of Control and Severance Plan Participation Agreement by and between Jeffery G. Black and Standard BioTools Inc. dated May 10, 2023 (FLUIDIGM CORP, Filed With SEC on May 15, 2023)
- Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) (Thermo Fisher Scientific, Filed With SEC on May 5, 2023)
- Change in Control Severance Agreement by and between the Company and Sriram Ryali dated January 27, 2023 (CODEXIS INC, Filed With SEC on February 27, 2023)
- Change in Control Severance Agreement by and between the Company and Margaret Fitzgerald dated October 10, 2022 (CODEXIS INC, Filed With SEC on February 27, 2023)
- 23andMe Holding Co. Change in Control Separation Plan (VG Acquisition Corp., Filed With SEC on December 9, 2022)
- Change in Control Severance Agreement by and between the Company and Kevin Norrett dated September 12, 2022 (CODEXIS INC, Filed With SEC on November 4, 2022)
- Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and (ARYA Sciences Acquisition Corp III, Filed With SEC on August 2, 2022)
- Repligen Corporation Amended and Restated Severance and Change in Control Plan, effective as of May 26, 2022 (Repligen Corporation, Filed With SEC on June 1, 2022)
- Change in Control and Severance Agreement by and between Berkeley Lights and Siddhartha Kadia (Berkeley Lights, Inc., Filed With SEC on May 9, 2022)
- Change in Control and Severance Agreement, by and between the Registrant and Denis Zaccarin, Ph.D. effective November 4, 2020 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on May 6, 2022)
- Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Gwen Weld dated April 12, 2022 (ARYA Sciences Acquisition Corp III, Filed With SEC on May 3, 2022)
- Executive Change in Control Severance Plan (Bio-Rad Laboratories, Filed With SEC on February 11, 2022)
- Form of Change in Control and Severance Agreement for executive officers (Basis Global Technologies, Inc., Filed With SEC on January 14, 2022)
- Alpha Teknova, Inc. Executive Severance and Change in Control Plan (Alpha Teknova, Inc., Filed With SEC on June 21, 2021)
- Form of Change in Control Severance Agreement (Codex DNA, Inc., Filed With SEC on May 28, 2021)
- Change of Control Agreement, dated April 16, 2021, between Waters Corporation and Amol Chaubal (Waters Corporation, Filed With SEC on May 6, 2021)
- Amended Change in Control and Severance Agreement by and between the Registrant and Christian O. Henry dated February 3, 2021 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 26, 2021)
- Change in Control and Severance Agreement by and between the Registrant and Christian O. Henry effective September 14, 2020 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 26, 2021)
- Form of Change in Control and Severance Agreement for executive officers (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 26, 2021)
- CEO Change in Control and Severance Agreement between the Registrant and Dr. Omid Farokhzad (Seer, Inc., Filed With SEC on November 30, 2020)
- Key Executive Change in Control and Severance Plan, and form of Participation Agreement thereunder (Seer, Inc., Filed With SEC on November 30, 2020)
- Change in Control and Severance Agreement by and between the Company and Susan G. Kim effective as of September 28, 2020 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on November 3, 2020)
- Fluidigm Corporation 2020 Change of Control and Severance Plan (FLUIDIGM CORP, Filed With SEC on August 7, 2020)
- Form Executive Change in Control Severance Agreement (Berkeley Lights, Inc., Filed With SEC on July 13, 2020)
- Form of Amended and Restated Change in Control Severance Agreement between the Company and certain of its officers (CODEXIS INC, Filed With SEC on November 6, 2019)
- Repligen Corporation Named Executive Officer Severance and Change in Control Plan, effective as of June 13, 2019 (Repligen Corporation, Filed With SEC on June 19, 2019)